- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Evelo Biosciences is a biotechnology business based in the US. Evelo Biosciences shares (EVLO) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.00 – an increase of 25% over the previous week. Evelo Biosciences employs 66 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy Evelo Biosciences stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Evelo Biosciences stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – EVLO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Evelo Biosciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Evelo Biosciences stock price (PINK: EVLO)
Use our graph to track the performance of EVLO stocks over time.Evelo Biosciences shares at a glance
Information last updated 2024-11-20.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $0.00 - $0.10 |
| 50-day moving average | $0.00 |
| 200-day moving average | $0.02 |
| Wall St. target price | $10.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-15.64 |
Evelo Biosciences price performance over time
Historical closes compared with the close of $0.0005 from 2024-12-20
| 1 week (2024-12-13) | 25.00% |
|---|---|
| 1 month (2024-11-22) | -66.67% |
| 3 months (2024-09-20) | 400.00% |
| 6 months (2024-06-21) | -99.17% |
| 1 year (2023-12-21) | -99.11% |
|---|---|
| 2 years (2022-12-21) | -100.00% |
| 3 years (2021-12-21) | 158.8 |
| 5 years (2019-12-20) | 83.4 |
Evelo Biosciences financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -83.25% |
| Return on equity TTM | -6232.76% |
| Profit margin | 0% |
| Book value | $-1.42 |
| Market Capitalization | $28,474 |
TTM: trailing 12 months
Evelo Biosciences share dividends
We're not expecting Evelo Biosciences to pay a dividend over the next 12 months.
Have Evelo Biosciences's shares ever split?
Evelo Biosciences's shares were split on a 1:20 basis on 29 June 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Evelo Biosciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Evelo Biosciences shares which in turn could have impacted Evelo Biosciences's share price.
Evelo Biosciences share price volatility
Over the last 12 months, Evelo Biosciences's shares have ranged in value from as little as $0.0001 up to $0.099. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Evelo Biosciences's is 1.304. This would suggest that Evelo Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Evelo Biosciences overview
Evelo Biosciences, Inc. , a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. .
Frequently asked questions
nullWhat percentage of Evelo Biosciences is owned by insiders or institutions?
Currently 0.136% of Evelo Biosciences shares are held by insiders and 12.854% by institutions. How many people work for Evelo Biosciences?
Latest data suggests 66 work at Evelo Biosciences. When does the fiscal year end for Evelo Biosciences?
Evelo Biosciences's fiscal year ends in December. Where is Evelo Biosciences based?
Evelo Biosciences's address is: 620 Memorial Drive, Cambridge, MA, United States, 02139 What is Evelo Biosciences's ISIN number?
Evelo Biosciences's international securities identification number is: US2997341035 What is Evelo Biosciences's CUSIP number?
Evelo Biosciences's Committee on Uniform Securities Identification Procedures number is: 299734103
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question